AI-Enhanced Chronic Obstructive Sleep Apnea Coach Market Report 2026

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market size has grown rapidly in recent years. It will grow from $1.61 billion in 2025 to $1.92 billion in 2026 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to increasing prevalence of sleep apnea and respiratory disorders, rising awareness of sleep health management, growth of home-based sleep monitoring solutions, expansion of digital health platforms, increased clinical focus on therapy compliance.

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market size is expected to see rapid growth in the next few years. It will grow to $3.88 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled chronic disease management tools, rising demand for remote patient monitoring solutions, expansion of personalized digital therapeutics, growing integration with connected medical devices, increasing healthcare shift toward preventive care models. Major trends in the forecast period include increasing adoption of continuous sleep and respiratory monitoring, rising use of AI-driven therapy adherence coaching, growing integration of wearable sleep diagnostics, expansion of personalized sleep health platforms, enhanced focus on proactive disease management.

The rising prevalence of sleep disorders is expected to drive the growth of the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market in the coming years. Sleep disorders are medical conditions that disrupt normal sleep, affecting sleep quality, overall health, and daily functioning. These disorders are increasing mainly due to heightened stress levels, as modern work pressures, academic demands, and excessive screen time contribute to anxiety and disturbed sleep cycles. An AI-enhanced chronic obstructive sleep apnea coach manages sleep disorders by monitoring breathing and sleep patterns, providing personalized guidance and therapy support, enabling early detection of complications, and promoting better sleep quality and overall health. For example, in November 2023, the National Health Service, a UK government health statistics agency, reported that the proportion of young people aged 17 to 23 years experiencing sleep problems three or more times in the past week increased slightly to 64.9%, compared to 64% in 2022. Consequently, the rising prevalence of sleep disorders is fueling the growth of the AI-enhanced chronic obstructive sleep apnea coach market.

Key companies in the AI-enhanced chronic obstructive sleep apnea coach market are focusing on developing advanced products such as positive airway pressure (PAP) devices, which deliver personalized therapy and enable remote monitoring through AI-driven insights. PAP devices provide a steady or adjustable airflow through a mask to keep airways open during sleep, preventing collapse in obstructive sleep apnea patients and improving breathing and sleep quality. For instance, in February 2024, ResMed Inc., a US-based medical device and digital health company, launched the AirCurve 11 series bilevel devices. These devices provide two levels of support - higher pressure during inhalation and lower pressure during exhalation - making it easier for healthcare providers to treat sleep apnea and helping patients stay on therapy. The AirCurve 11 series is built on the AirSense 11 platform and includes digital features such as secure data transfer via cellular communication, automatic software updates, and patient engagement tools like the myAir app. The series includes models for both obstructive and central sleep apnea, aiming to improve comfort and compliance through personalized therapy support. The devices are currently available in the U.S., with a global rollout planned.

In May 2024, Aeroflow Sleep, a US-based provider of continuous positive airway pressure therapy and sleep apnea supplies via insurance, partnered with EnsoData to help care teams in the United States proactively manage patients with chronic obstructive sleep apnea using predictive AI. Through this partnership, Aeroflow Sleep aims to enhance patient adherence by leveraging EnsoData’s PAP therapy prediction model, EnsoTherapy, to identify patients at risk of non-compliance, deliver timely coaching support, and optimize long-term outcomes in sleep apnea care. EnsoData is a US-based AI company specializing in predictive sleep analytics and data-driven solutions for sleep medicine.

Major companies operating in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market are Koninklijke Philips N.V., ResMed Inc., Sleep Number Corporation, Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Verily Life Sciences LLC, Natus Medical Incorporated, SomnoMed Limited, BMC Medical Co.,Ltd., Eight Sleep,Inc., Sleepiz AG, Sleep.ai B.V. (SleepScore Labs), EnsoData,Inc., SovaSage,Inc., Somnics Inc., Sleep Doctor,LLC, Sommetrics,Inc., Nyxoah S.A., Neru Health Inc., Apnea-Tech Limited.

North America was the largest region in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the AI-enhanced chronic obstructive sleep apnea coach market by increasing costs of imported wearable sensors, respiratory monitoring components, semiconductors, and connected medical devices used in continuous monitoring systems. North America and Europe are most affected due to reliance on imported electronics and cloud infrastructure hardware, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are raising solution deployment costs and slowing adoption in price-sensitive homecare settings. However, they are also encouraging regional device assembly, local software development, and increased investment in domestically produced digital health platforms.

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market statistics, including artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market share, detailed artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach industry. This artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI)-enhanced chronic obstructive sleep apnea (OSA) coach is a digital health solution that continuously monitors sleep patterns and respiratory metrics to support effective disease management. It analyzes real-time data and provides personalized guidance to optimize therapy adherence and lifestyle adjustments. The system allows proactive identification of complications, improves treatment effectiveness, and enhances overall sleep quality.

The main components of an AI-enhanced chronic OSA coach include software, hardware, and services. Software consists of AI-driven applications and algorithms that analyze sleep data, deliver personalized insights, and provide real-time coaching for effective management of sleep apnea. Deployment modes include cloud-based and on-premises solutions, applied in settings such as home care, sleep clinics, hospitals, and research institutes. Key end-users include patients, healthcare providers, sleep specialists, and others.

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market consists of revenues earned by entities by providing services such as remote patient monitoring, therapy adherence support, personalized health coaching, teleconsultation, sleep data analysis, and patient education and engagement. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market also includes sales of wearable sleep trackers, smart continuous positive airway pressure devices, connected pulse oximeters, and cloud-based monitoring platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.